Dyne has aligned with the U.S. Food and Drug Administration (FDA) on the HARMONIA Phase 3 trial design and protocol. HARMONIA is intended to serve as a confirmatory trial to support conversion of ...
The FDA has put a partial clinical hold on PepGen’s phase 2 mus | The FDA has put a partial clinical hold on PepGen’s phase 2 muscle wasting trial after reviewing preclinical data, continuing the stop ...
PepGen said the Food and Drug Administration is pausing a trial evaluating its potential treatment for myotonic dystrophy. The biotechnology company said Wednesday the FDA put the Phase 2 trial on ...
The timing of the partial hold is “odd,” according to analysts at Stifel, who noted that the preclinical data the FDA took ...
Comedian Gilbert Gottfried, shown in a 2016 photo, died on Tuesday, April 12, from recurrent ventricular tachycardia due to myotonic dystrophy type II. Scott Roth Scott Roth/Invision/AP Comedian ...
Myotonic dystrophy is a hereditary degenerative neuromuscular disease that occurs mainly in adults, affecting about 50,000 people only in Spain. Symptoms range from difficulty walking and myotonia ...
DUBLIN--(BUSINESS WIRE)--The "Myotonic Dystrophy - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Myotonic Dystrophy - Pipeline Insight, 2023" report ...
Shares of PepGen slid after the Food and Drug Administration put a partial clinical hold on a study of its treatment for Myotonic Dystrophy, a genetic disorder that causes progressive muscle loss and ...
Comedian Gilbert Gottfried died last week after a long illness, his family announced. His publicist revealed in a statement to multiple publications, including People, Gottfried had "recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results